文献速递妇科生殖医学

迈向子宫内膜异位症相关症状的全面管理:超越药物与手术治疗的二元对立

Towards comprehensive management of symptomatic endometriosis: beyond the dichotomy of medical versus surgical treatment.
PubMed 文献 · Hum Reprod · 2024-01-01

本文为综述,讨论子宫内膜异位症相关疼痛的治疗选择不应局限于药物或手术的二元对立。药物与手术在缓解疼痛症状上似乎效果相似,药物对严重痛经更有效,手术对纤维化病灶浸润后盆腔所致严重深部性交痛更有效。约四分之三的腹膜浅表和卵巢子宫内膜异位症患者及三分之二浸润性纤维化病灶患者最终对药物治疗满意。作者主张以症状为导向而非病灶导向的治疗,并强调多学科综合管理与共情。

要点

  • 药物与手术在缓解疼痛症状上似乎效果相似,药物对严重痛经更有效,手术对纤维化病灶所致严重深部性交痛更有效。
  • 约四分之三腹膜浅表和卵巢子宫内膜异位症患者、三分之二浸润性纤维化病灶患者最终对药物治疗满意。
  • 激素药物诱导疾病缓解但不治愈,停药后症状预期复发;病灶切除后亦应使用药物,术后每年累积症状和病灶复发率约10%。

核心结论

  • 子宫内膜异位症相关疼痛的治疗应以症状为导向而非病灶导向,真正的选择可能不是药物与手术之间,而是单纯药物治疗与手术加术后药物治疗之间。
  • 以患者为中心的医学是优先事项,是否或何时采用手术或选择药物方案仍是每位女性自己的决定权。

研究设计与样本

  • 本文为综述,讨论子宫内膜异位症相关疼痛的全面管理。

主要发现

  • 药物与手术在缓解疼痛症状上似乎效果相似,药物对严重痛经更有效,手术对纤维化病灶浸润后盆腔所致严重深部性交痛更有效。
  • 约四分之三腹膜浅表和卵巢子宫内膜异位症患者及三分之二浸润性纤维化病灶患者最终对药物治疗满意,其余可能出现副作用导致不依从。
  • 激素药物诱导疾病缓解但不治愈子宫内膜异位症,停药后症状预期复发;病灶切除后亦应使用相同药物以预防术后每年约10%的累积症状和病灶复发率。
  • 浅表和卵巢子宫内膜异位症的手术通常安全;存在纤维化浸润病灶时,发病率因个体外科医生技术、是否需要肠切除和输尿管再植入等先进操作以及多学科团队中结直肠外科医生和泌尿科医生的可用性而差异很大。
  • 已发表结果的普遍性对药物治疗足够,但对手术非常有限。

关键数值与推荐

  • 雌激素-孕激素联合方案和孕激素单药治疗通常安全且耐受良好,前提是无重大禁忌症。
  • 腹膜浅表和卵巢子宫内膜异位症约四分之三患者、浸润性纤维化病灶约三分之二患者最终对药物治疗满意。
  • 术后每年累积症状和病灶复发率约10%。

临床怎么用

  • 治疗应症状导向而非病灶导向,药物与手术似乎效果相似,药物对严重痛经更成功,手术对纤维化病灶所致严重深部性交痛更成功。
  • 激素药物诱导缓解但不治愈,停药后症状预期复发,病灶切除后亦应使用药物以预防复发。
  • 疼痛管理可能需要包括心理学家、性学家、物理治疗师、营养师和疼痛治疗师的多学科团队综合护理。
  • 医疗保健提供者应提供共情,简单清晰的解释、对不确定性的诚实沟通、邀请患者共享医疗决策可增加信任。
  • 是否或何时采用手术或选择药物方案仍是每位女性自己的决定权。

局限性

  • 随机对照试验的稳健数据匮乏。
  • 已发表结果的普遍性对药物治疗足够,但对手术非常有限。
  • 外周和中枢敏化的作用尚未完全理解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Except when surgery is the only option because of organ damage, the presence of suspicious lesions, or the desire to conceive, women with endometriosis-associated pain often face a choice between medical and surgical treatment. In theory, the description of the potential benefits and potential harms of the two alternatives should be standardized, unbiased, and based on strong evidence, enabling the patient to make an informed decision. However, doctor's opinion, intellectual competing interests, local availability of specific services and (mis)information obtained from social media, and online support groups can influence the type of advice given and affect patients' choices. This is compounded by the paucity of robust data from randomized controlled trials, and the anxiety of distressed women who are eager to do anything to alleviate their disabling symptoms. Vulnerable patients are more likely to accept the suggestions of their healthcare provider, which can lead to unbalanced and physician-centred decisions, whether in favour of either medical or surgical treatment. In general, treatments should be symptom-orientated rather than lesion-orientated. Medical and surgical modalities appear to be similarly effective in reducing pain symptoms, with medications generally more successful for severe dysmenorrhoea and surgery more successful for severe deep dyspareunia caused by fibrotic lesions infiltrating the posterior compartment. Oestrogen-progestogen combinations and progestogen monotherapies are generally safe and well tolerated, provided there are no major contraindications. About three-quarters of patients with superficial peritoneal and ovarian endometriosis and two-thirds of those with infiltrating fibrotic lesions are ultimately satisfied with their medical treatment although the remainder may experience side effects, which may result in non-compliance. Surgery for superficial and ovarian endometriosis is usually safe. When fibrotic infiltrating lesions are present, morbidity varies greatly depending on the skill of the individual surgeon, the need for advanced procedures, such as bowel resection and ureteral reimplantation, and the availability of expert colorectal surgeons and urologists working together in a multidisciplinary approach. The generalizability of published results is adequate for medical treatment but very limited for surgery. Moreover, on the one hand, hormonal drugs induce disease remission but do not cure endometriosis, and symptom relapse is expected when the drugs are discontinued; on the other hand, the same drugs should be used after lesion excision, which also does not cure endometriosis, to prevent an overall cumulative symptom and lesion recurrence rate of 10% per postoperative year. Therefore, the real choice may not be between medical treatment and surgery, but between medical treatment alone and surgery plus postoperative medical treatment. The experience of pain in women with endometriosis is a complex phenomenon that is not exclusively based on nociception, although the role of peripheral and central sensitization is not fully understood. In addition, trauma, and especially sexual trauma, and pelvic floor disorders can cause or contribute to symptoms in many individuals with chronic pelvic pain, and healthcare providers should never take for granted that diagnosed or suspected endometriosis is always the real, or the sole, origin of the referred complaints. Alternative treatment modalities are available that can help address most of the additional causes contributing to symptoms. Pain management in women with endometriosis may be more than a choice between medical and surgical treatment and may require comprehensive care by a multidisciplinary team including psychologists, sexologists, physiotherapists, dieticians, and pain therapists. An often missing factor in successful treatment is empathy on the part of healthcare providers. Being heard and understood, receiving simple and clear explanations and honest communication about uncertainties, being invited to share medical decisions after receiving detailed and impartial information, and being reassured that a team member will be available should a major problem arise, can greatly increase trust in doctors and transform a lonely and frustrating experience into a guided and supported journey, during which coping with this chronic disease is gradually learned and eventually accepted. Within this broader scenario, patient-centred medicine is the priority, and whether or when to resort to surgery or choose the medical option remains the prerogative of each individual woman.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Mijatovic V, Vercellini P. Towards comprehensive management of symptomatic endometriosis: beyond the dichotomy of medical versus surgical treatment. Hum Reprod. 2024. PMID: 38199787. doi:10.1093/humrep/dead262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。